Selected article for: "low value and present study"

Author: ten Oever, Jaap; Kox, Matthijs; van de Veerdonk, Frank L; Mothapo, Khutso M; Slavcovici, Adriana; Jansen, Tim L; Tweehuysen, Lieke; Giamarellos-Bourboulis, Evangelos J; Schneeberger, Peter M; Wever, Peter C; Stoffels, Monique; Simon, Anna; van der Meer, Jos WM; Johnson, Melissa D; Kullberg, Bart-Jan; Pickkers, Peter; Pachot, Alexandre; Joosten, Leo AB; Netea, Mihai G
Title: The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
  • Document date: 2014_11_19
  • ID: 0zkeoa1z_26
    Snippet: In the present study, we demonstrate that sTLR2 and sTLR4 are released in-vitro and in-vivo after challenge with microbial ligands such as LPS. Significantly elevated plasma concentrations of sTLRs are present in the circulation during experimental human endotoxemia, and high circulating concentrations of sTLR4 are found in patients with infections compared to patients with non-infectious inflammation, as well as in patients with bacterial infect.....
    Document: In the present study, we demonstrate that sTLR2 and sTLR4 are released in-vitro and in-vivo after challenge with microbial ligands such as LPS. Significantly elevated plasma concentrations of sTLRs are present in the circulation during experimental human endotoxemia, and high circulating concentrations of sTLR4 are found in patients with infections compared to patients with non-infectious inflammation, as well as in patients with bacterial infections compared with viral infections. However, the value of sTLR2 and sTLR4 as additional diagnostic biomarkers is low as both new markers do not surpass CRP in accuracy.

    Search related documents:
    Co phrase search for related documents
    • bacterial infection and human endotoxemia: 1
    • bacterial infection and infection patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bacterial infection and non infectious inflammation: 1, 2, 3
    • bacterial infection and plasma concentration: 1, 2
    • bacterial infection and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bacterial infection patient and diagnostic biomarker: 1
    • bacterial infection patient and infection patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • bacterial infection patient and present study: 1
    • circulating concentration and plasma concentration: 1, 2
    • circulating concentration and present study: 1, 2
    • diagnostic biomarker and infection patient: 1
    • diagnostic biomarker and present study: 1, 2, 3, 4, 5, 6
    • experimental human endotoxemia and human endotoxemia: 1, 2, 3, 4, 5
    • experimental human endotoxemia and non infectious inflammation: 1
    • experimental human endotoxemia and present study: 1
    • human endotoxemia and non infectious inflammation: 1, 2
    • human endotoxemia and present study: 1
    • infection patient and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25